Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,099.66
(
-0.13%
)
US TECH 100
25,898.40
(
0.10%
)
Dow Jones
49,363.69
(
-0.17%
)
Brent Oil
94.85
(
4.60%
)
Bitcoin
75,270.48
(
-0.82%
)
News Focus
News Focus

Replies to post #27751 on Relief Therapeutics Holding AG (RLFTF)

Replies to #27751 on Relief Therapeutics Holding AG (RLFTF)
icon url

elllk

10/23/20 5:50 PM

#27752 RE: PennyWorld #27751

Yes, in that interview Javitt did also say that PhaseBio was targeting the VPAC2 receptor in the blood vessels.